For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

PHILADELPHIA - Century Therapeutics, Inc. (NASDAQ: IPSC), a biotechnology firm with a market capitalization of $77.32 million ...

A WOMAN from Salisbury had her head shaved to raise money for charity after being diagnosed with MS. Hannah Schmidt, 35, is a mum of three boys and the family lives in Salisbury. In December 2020, she ...

Rese-cel, previously called CABA-201, is a CAR T-cell therapy that's designed to treat MS by depleting B-cells.

The National Multiple Sclerosis Society (NMSS) has launched the first national guidelines for the treatment of Multiple ...

Recent important developments presented at the European Congress for Treatment and Research in Multiple Sclerosis and other meetings were also considered.

Additionally, Arvinas has initiated a Phase 1 trial of the PROTAC LRRK2 degrader ARV-102 for Parkinson's disease and expects to present data from multiple ... patients with B-cell lymphomas.” ...

The company expects the last relapsing-remitting multiple sclerosis patient to complete the trial by the third quarter of this year. Credit: illustrissima ...

The Abu Dhabi Stem Cells Center (ADSCC ... diseases such as Alzheimer's, multiple sclerosis, Parkinson's, and diabetes. To treat these conditions, ADSCC is actively conducting multiple research ...